Decision to adopt medical technology under the National Health Insurance System in Taiwan: case study of new molecular targeted drugs among non‐small cell lung cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2753|21|5|808-816

ISSN： 1356-1294

Source： JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol.21, Iss.5, 2015-10, pp. : 808-816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapy in lung cancer

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 3, 2015-04 ,pp. : 370-378

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gender Differences in Treatment Outcomes among Patients with Non-Small Cell Lung Cancer Given a Combination of Carboplatin and Paclitaxel

By  

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

New Drugs in the Palliative Chemotherapy of Advanced Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 416-421

Karger

Access to resources Recommend Favorite

Erlotinib in Patients with Previously Irradiated, Recurrent Brain Metastases from Non-Small Cell Lung Cancer: Two Case Reports

By  

Oncology Research and Treatment, Vol. 31, Iss. 3, 2008-02 ,pp. : 123-126

Karger

Access to resources Recommend Favorite

Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib

By  

Oncology, Vol. 79, Iss. 5-6, 2011-04 ,pp. : 423-429

Karger

Access to resources Recommend Favorite